Back to Results
First PageMeta Content
Experimental cancer treatments / Gynaecological cancer / Ovarian cancer / Applied genetics / Medical research / Gene therapy / Oncolytic virus / H19 / Cancer / Medicine / Biology / Viruses


Protocol No: BC[removed]Phase 1/2a, Dose-Escalation, Safety, Pharmacokinetic, and Preliminary Efficacy Study of Intraperitoneal Administration of DTA-H19 in Subjects with Advanced Stage Ovarian Cancer Presentation to the
Add to Reading List

Document Date: 2014-01-06 12:50:54


Open Document

File Size: 862,10 KB

Share Result on Facebook

Facility

Gynecology University of Pennsylvania Medical Center American Cancer Society Female Cancers / /

MedicalCondition

ovarian cancer / measles virus / American Cancer Society Female Cancers / /

MedicalTreatment

Gene therapy / Intraperitoneal therapy / Intravenous therapy / viral therapy / /

Organization

University of Pennsylvania / Intraperitoneal Administration of DTA-H19 / OR CR / Associate Professor Department of Obstetrics / Recombinant DNA Advisory Committee / /

Person

George Coukos / /

Technology

Gene therapy / Recombinant DNA / /

SocialTag